DK562189D0 - Fremgangsmaade til isolering af biologisk aktive forbindelser - Google Patents

Fremgangsmaade til isolering af biologisk aktive forbindelser

Info

Publication number
DK562189D0
DK562189D0 DK562189A DK562189A DK562189D0 DK 562189 D0 DK562189 D0 DK 562189D0 DK 562189 A DK562189 A DK 562189A DK 562189 A DK562189 A DK 562189A DK 562189 D0 DK562189 D0 DK 562189D0
Authority
DK
Denmark
Prior art keywords
insulating
procedure
biologically active
active compounds
factor viii
Prior art date
Application number
DK562189A
Other languages
English (en)
Other versions
DK562189A (da
DK162233C (da
DK162233B (da
Inventor
Per Kaersgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of DK562189D0 publication Critical patent/DK562189D0/da
Priority to DK562189A priority Critical patent/DK162233C/da
Priority to ZA908599A priority patent/ZA908599B/xx
Priority to SK5371-90A priority patent/SK537190A3/sk
Priority to CS905371A priority patent/CZ537190A3/cs
Priority to EP90917201A priority patent/EP0524172B1/en
Priority to HU9201551A priority patent/HU214905B/hu
Priority to DE69017050T priority patent/DE69017050T2/de
Priority to AU67470/90A priority patent/AU631471B2/en
Priority to PCT/DK1990/000279 priority patent/WO1991007438A1/en
Priority to ES90917201T priority patent/ES2068404T3/es
Priority to AT90917201T priority patent/ATE118508T1/de
Priority to JP3500067A priority patent/JP2509407B2/ja
Priority to CA002073012A priority patent/CA2073012C/en
Priority to UA94020494A priority patent/UA29421C2/uk
Priority to SU905052211A priority patent/RU2055593C1/ru
Priority to SI9012105A priority patent/SI9012105A/sl
Priority to US07/610,480 priority patent/US5245014A/en
Priority to NZ236004A priority patent/NZ236004A/xx
Priority to YU210590A priority patent/YU47524B/sh
Priority to PT95830A priority patent/PT95830B/pt
Priority to IE402290A priority patent/IE66836B1/en
Priority to IL9627790A priority patent/IL96277A/en
Priority to PL90287703A priority patent/PL164894B1/pl
Priority to CN90109030A priority patent/CN1044121C/zh
Publication of DK562189A publication Critical patent/DK562189A/da
Publication of DK162233B publication Critical patent/DK162233B/da
Application granted granted Critical
Publication of DK162233C publication Critical patent/DK162233C/da
Priority to FI922105A priority patent/FI103510B/fi
Priority to NO921839A priority patent/NO180741C/no
Priority to BG96316A priority patent/BG61231B1/bg
Priority to HRP-2105/90A priority patent/HRP930277A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Amplifiers (AREA)
  • Cephalosporin Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Networks Using Active Elements (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK562189A 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii DK162233C (da)

Priority Applications (28)

Application Number Priority Date Filing Date Title
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
ZA908599A ZA908599B (en) 1989-11-09 1990-10-26 A method for isolating biologically active compounds
SK5371-90A SK537190A3 (en) 1989-11-09 1990-11-01 Method of the factor viii isolation
CS905371A CZ537190A3 (cs) 1989-11-09 1990-11-01 Způsob izolování faktoru VIII
SU905052211A RU2055593C1 (ru) 1989-11-09 1990-11-05 Способ выделения фактора viii из других белков в плазме крови
HU9201551A HU214905B (hu) 1989-11-09 1990-11-05 Eljárás VIII. faktor izolálására
DE69017050T DE69017050T2 (de) 1989-11-09 1990-11-05 Verfahren zur isolierung von faktor viii.
AU67470/90A AU631471B2 (en) 1989-11-09 1990-11-05 A method for isolating factor viii
PCT/DK1990/000279 WO1991007438A1 (en) 1989-11-09 1990-11-05 A method for isolating factor viii
ES90917201T ES2068404T3 (es) 1989-11-09 1990-11-05 Un metodo para aislar el factor viii.
AT90917201T ATE118508T1 (de) 1989-11-09 1990-11-05 Verfahren zur isolierung von faktor viii.
JP3500067A JP2509407B2 (ja) 1989-11-09 1990-11-05 生物学的に活性な化合物の単離方法
CA002073012A CA2073012C (en) 1989-11-09 1990-11-05 Method for isolating factor viii
UA94020494A UA29421C2 (uk) 1989-11-09 1990-11-05 Спосіб виділення фактора vііі з інших білків в плазмі крові
EP90917201A EP0524172B1 (en) 1989-11-09 1990-11-05 A method for isolating factor viii
NZ236004A NZ236004A (en) 1989-11-09 1990-11-07 Isolation of factor viii using gel filtration
US07/610,480 US5245014A (en) 1989-11-09 1990-11-07 Method for isolating factors viii from plasma by gel filtration chromatography under group separation conditions
SI9012105A SI9012105A (sl) 1989-11-09 1990-11-07 Postopek za izoliranje biološko aktivnih spoji
YU210590A YU47524B (sh) 1989-11-09 1990-11-07 Postupak za izolovanje faktora viii iz drugih proteina u krvnoj plazmi
PT95830A PT95830B (pt) 1989-11-09 1990-11-08 Processo para o isolamento do factor viii sob a forma de uma fraccao pura directamente de plasma mediante filtracao em gel
IE402290A IE66836B1 (en) 1989-11-09 1990-11-08 A method for isolating biologically active compounds
IL9627790A IL96277A (en) 1989-11-09 1990-11-08 Method for isolating factor IIIV
PL90287703A PL164894B1 (pl) 1989-11-09 1990-11-09 Sposób izolowania c zynnika krzepniecia VIII PL PL PL PL PL PL PL PL
CN90109030A CN1044121C (zh) 1989-11-09 1990-11-09 分离凝血因子viii配合物的方法
BG96316A BG61231B1 (en) 1989-11-09 1992-05-08 A method for isolating factor viii
NO921839A NO180741C (no) 1989-11-09 1992-05-08 Fremgangsmåte for isolering av Faktor VIII
FI922105A FI103510B (fi) 1989-11-09 1992-05-08 Menetelmä tekijän VIII eristämiseksi
HRP-2105/90A HRP930277A2 (en) 1989-11-09 1993-03-08 A method for isolating biologically active compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
DK562189 1989-11-09

Publications (4)

Publication Number Publication Date
DK562189D0 true DK562189D0 (da) 1989-11-09
DK562189A DK562189A (da) 1991-05-10
DK162233B DK162233B (da) 1991-09-30
DK162233C DK162233C (da) 1992-03-16

Family

ID=8144000

Family Applications (1)

Application Number Title Priority Date Filing Date
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii

Country Status (26)

Country Link
US (1) US5245014A (da)
EP (1) EP0524172B1 (da)
JP (1) JP2509407B2 (da)
CN (1) CN1044121C (da)
AT (1) ATE118508T1 (da)
AU (1) AU631471B2 (da)
BG (1) BG61231B1 (da)
CA (1) CA2073012C (da)
CZ (1) CZ537190A3 (da)
DE (1) DE69017050T2 (da)
DK (1) DK162233C (da)
ES (1) ES2068404T3 (da)
FI (1) FI103510B (da)
HU (1) HU214905B (da)
IE (1) IE66836B1 (da)
IL (1) IL96277A (da)
NO (1) NO180741C (da)
NZ (1) NZ236004A (da)
PL (1) PL164894B1 (da)
PT (1) PT95830B (da)
RU (1) RU2055593C1 (da)
SK (1) SK537190A3 (da)
UA (1) UA29421C2 (da)
WO (1) WO1991007438A1 (da)
YU (1) YU47524B (da)
ZA (1) ZA908599B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0399321B1 (en) * 1989-05-24 1993-06-23 Miles Inc. Gel filtration of heat treated factor viii
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US6180371B1 (en) 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
US6290527B1 (en) * 1998-07-03 2001-09-18 Nippon Telegraph And Telephone Corp. Nippon telegraph and telephone corporation
BR0008405B1 (pt) 1999-02-22 2014-04-22 Baxter Int Composição de fator viii formulada sem a adição de albumina, uso de uma composição de fator viii, e, método de liofilizar uma formulação farmacêutica aquosa
JP2002348300A (ja) * 1999-04-12 2002-12-04 Fujimori Kogyo Co Ltd 血液凝固第ｖｉｉｉ因子および血液凝固第ｖｉｉｉ因子／フォン・ビルブラント因子複合体の精製方法
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
PL1750733T3 (pl) 2004-05-03 2014-05-30 Univ Emory Sposób podawania świńskiego czynnika krzepnięcia VIII pozbawionego domeny B
WO2006021584A2 (en) * 2004-08-27 2006-03-02 Novo Nordisk Health Care Ag Purification of factor xiii polypeptides from biological materials
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
US20100168018A1 (en) * 2008-11-07 2010-07-01 Baxter International Inc. Factor viii formulations
DK3133157T3 (da) * 2010-03-30 2019-08-12 Octapharma Ag Fremgangsmåde til oprensning af vitamin k-afhængige proteiner
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
EP2635297B1 (en) 2010-11-05 2019-02-27 Baxalta GmbH A new variant of antihemophilic factor viii having increased specific activity
WO2012082933A1 (en) 2010-12-15 2012-06-21 Baxter International, Inc. Eluate collection using conductivity gradient
CN103506080A (zh) * 2012-06-19 2014-01-15 汪志友 一种用于分离纯化凝血因子viii的介质及其制备方法
US11078518B2 (en) * 2012-09-28 2021-08-03 Chugai Seiyaku Kabushiki Kaisha Method for evaluating blood coagulation reaction
US9663553B2 (en) * 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
EP0321835B1 (en) * 1987-12-21 1994-09-28 Miles Inc. Gel filteration of factor VIII
WO1989009784A1 (en) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production of heat-stable factor viii concentrate
EP0399321B1 (en) * 1989-05-24 1993-06-23 Miles Inc. Gel filtration of heat treated factor viii

Also Published As

Publication number Publication date
HU214905B (hu) 1998-07-28
PT95830B (pt) 1997-11-28
ATE118508T1 (de) 1995-03-15
JP2509407B2 (ja) 1996-06-19
NZ236004A (en) 1991-11-26
CA2073012A1 (en) 1991-05-10
DK562189A (da) 1991-05-10
UA29421C2 (uk) 2000-11-15
NO921839L (no) 1992-07-08
CZ537190A3 (cs) 1998-05-13
DE69017050T2 (de) 1995-06-14
CN1051732A (zh) 1991-05-29
SK278640B6 (en) 1997-12-10
PT95830A (pt) 1991-09-30
RU2055593C1 (ru) 1996-03-10
HUT60511A (en) 1992-09-28
FI103510B1 (fi) 1999-07-15
FI922105A (fi) 1992-05-08
NO921839D0 (no) 1992-05-08
YU210590A (sh) 1993-05-28
IE66836B1 (en) 1996-02-07
IL96277A0 (en) 1991-08-16
NO180741C (no) 1997-06-11
YU47524B (sh) 1995-10-03
DK162233C (da) 1992-03-16
JPH05501557A (ja) 1993-03-25
IE904022A1 (en) 1991-05-22
ES2068404T3 (es) 1995-04-16
DE69017050D1 (de) 1995-03-23
BG61231B1 (en) 1997-03-31
DK162233B (da) 1991-09-30
SK537190A3 (en) 1997-12-10
US5245014A (en) 1993-09-14
NO180741B (no) 1997-03-03
IL96277A (en) 1995-07-31
CN1044121C (zh) 1999-07-14
AU6747090A (en) 1991-06-13
FI922105A0 (fi) 1992-05-08
BG96316A (bg) 1993-12-24
HU9201551D0 (en) 1992-08-28
FI103510B (fi) 1999-07-15
WO1991007438A1 (en) 1991-05-30
PL164894B1 (pl) 1994-10-31
EP0524172B1 (en) 1995-02-15
AU631471B2 (en) 1992-11-26
ZA908599B (en) 1991-07-31
PL287703A1 (en) 1991-12-02
CA2073012C (en) 1996-03-19
EP0524172A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
DK562189A (da) Fremgangsmaade til isolering af biologisk aktive forbindelser
DK442688A (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DK161524C (da) Fremgangsmaade til isolering af et praeparat af et osteogent protein samt et praeparat i stand til at fremme osteogenese fremstillet ved fremgangsmaaden
DK320287D0 (da) Fremgangsmaade til anvendelse af barl til udskillelse af fremmede proteiner
DK105988D0 (da) Apparat til adskillelse af blodkomponenter
IT8547835A1 (it) Procedimento di purificazione di proteine ossee
YU191387A (en) Process for extracting lipofilic proteins from host cells of pichia origin
CY1105206T1 (el) Διαδικασια για την εκχυλιση και χρησιμοποιηση υγρου επωασης απο σολομο του ατλαντικου
AU575496B2 (en) Porous membrane for separation of blood components and method for manufacture thereof
DE3788229D1 (de) Verfahren zur isolierung von ca 125-antigen.
GB2218991B (en) Enzymatic membrane method for the synthesis of peptides and the separation of optical isomers
DK398987D0 (da) Fremgangsmaade til fremstilling af blodprotein
DK0789767T3 (da) Fremgangsmåde til fremstilling af oprensede papilomavirusproteiner
AU582497B2 (en) Improved process for separation of acid gases
DK0428984T3 (da) Fremgangsmåde til fraskillelse af aminosyrer
ATE72756T1 (de) Verfahren zur herstellung eines biologischen stoffes.
AU8066387A (en) Process for fertilisation of vineyards
DK0401657T3 (da) Fremgangsmåde til C-terminal modificering af proteiner
DK526889D0 (da) Apparat til gennemfoerelse af membranskilleprocesser
ATE66931T1 (de) Verfahren zur scheidung und isolierung von nosiheptid.
DE3785852D1 (de) Verfahren zur chromatographischen trennung von metallionen.
KR920701461A (ko) 펩티드의 합성 및 분리를 위한 효소막법

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK